{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:32:05Z","timestamp":1787758325641,"version":"build-2784847793"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.4103\/bc.bc_25_22","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T06:52:40Z","timestamp":1663656760000},"page":"165-167","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Guillain\u2013Barr\u00e9 syndrome associated with vaccines in Veracruz, Mexico"],"prefix":"10.4103","volume":"8","author":[{"given":"Luis Del","family":"Carpio-Orantes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishar","family":"Sol\u00eds-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri Omar","family":"Piquet-Uscanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20240830","doi-asserted-by":"crossref","first-page":"119899","DOI":"10.1016\/j.jns.2021.119899","article-title":"Neurological symptoms in patients with COVID-19 as manifestation of severity and prognosis, the case of anosmia and dysgeusia","volume":"429","author":"Del Carpio-Orantes","year":"2021","journal-title":"J Neurol Sci"},{"key":"R2-8-20240830","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barr\u00e9 syndrome","volume":"32","author":"Haber","year":"2009","journal-title":"Drug Saf"},{"key":"R3-8-20240830","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1016\/j.vaccine.2018.05.119","article-title":"Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome","volume":"37","author":"Principi","year":"2019","journal-title":"Vaccine"},{"key":"R4-8-20240830","doi-asserted-by":"crossref","first-page":"782198","DOI":"10.3389\/fimmu.2022.782198","article-title":"Population-based incidence of Guillain-Barr\u00e9 syndrome during mass immunization with viral vaccines: A pooled analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R5-8-20240830","doi-asserted-by":"crossref","first-page":"e228879","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the vaccine safety datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R6-8-20240830","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.3201\/eid2712.211634","article-title":"Guillain-Barr\u00e9 syndrome associated with COVID-19 vaccination","volume":"27","author":"Shao","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R7-8-20240830","doi-asserted-by":"crossref","first-page":"108818","DOI":"10.1016\/j.clim.2021.108818","article-title":"Guillain-Barr\u00e9 syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine","volume":"230","author":"Garc\u00eda-Grimshaw","year":"2021","journal-title":"Clin Immunol"},{"key":"R8-8-20240830","doi-asserted-by":"crossref","first-page":"110792","DOI":"10.1016\/j.mehy.2022.110792","article-title":"Post-adenoviral-based vaccines Guillain-Barre syndrome: A proposed mechanism","volume":"160","author":"Kadkhoda","year":"2022","journal-title":"Med Hypotheses"},{"key":"R9-8-20240830","doi-asserted-by":"crossref","first-page":"286","DOI":"10.18071\/isz.74.0286","article-title":"A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN","volume":"74","author":"Tutar","year":"2021","journal-title":"Ideggyogy Sz"},{"key":"R10-8-20240830","doi-asserted-by":"crossref","first-page":"577691","DOI":"10.1016\/j.jneuroim.2021.577691","article-title":"Sensory Guillain-Barre syndrome following the ChAdO\u00d71 nCov-19 vaccine: Report of two cases and review of literature","volume":"359","author":"Min","year":"2021","journal-title":"J Neuroimmunol"}],"container-title":["Brain Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_25_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:14:02Z","timestamp":1787757242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_25_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/bc.bc_25_22","relation":{},"ISSN":["2394-8108"],"issn-type":[{"value":"2394-8108","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}